There's been a persistent call for insulin in particular to be made more affordable. California has authorized $100 million in funding to eventually produce a public generic insulin. Michigan Governor Gretchen Whitmer has called for her state to do the same thing, put about $150 million behind it. Some non-profit efforts include CivicaRx which is basically a cooperative of hospital systems that is planning to develop its own generic medications and they're starting with insulin.
Insulin was the poster child of overpriced life saving drugs, but a manufacturer finally capped the cost at $35. Vox’s Dylan Scott explains how pharmaceutical companies for decades managed to overprice drugs Americans desperately needed.
This episode was produced by Haleema Shah, edited by Amina Al-Sadi, fact-checked by Laura Bullard and Matt Collette, engineered by Patrick Boyd, and hosted by Sean Rameswaram.
Transcript at vox.com/todayexplained
Support Today, Explained by making a financial contribution to Vox! bit.ly/givepodcasts
Learn more about your ad choices. Visit podcastchoices.com/adchoices